Consensus Owens & Minor, Inc.

Equities

OMI

US6907321029

Market Closed - Nyse 04:00:02 2024-03-27 pm EDT 5-day change 1st Jan Change
27.95 USD +5.15% Intraday chart for Owens & Minor, Inc. +8.00% +45.04%

Evolution of the average Target Price on Owens & Minor, Inc.

Price target over the last 5 years

History of analyst recommendation changes

a7985cae837065f597c0fcc2374e.O35UdGqr_P5K7MSMoZUkHj02XEbM9KK6k-L5IVWz14s.eRdnJCicm6EYjqPAmddoKAxuPx6FzcPxpq2WWzDK-sFfPTI8X_yGki-5kQ~fb2050eea8a2e0691dc1bdf08fab3524
Citigroup Adjusts Owens & Minor's Price Target to $24 From $23, Keeps Neutral Rating MT
UBS Adjusts Owens & Minor Price Target to $27 From $26, Maintains Buy Rating MT
Barclays Raises Price Target on Owens & Minor to $23 From $21, Maintains Equalweight Rating MT
Barclays Adjusts Owens & Minor's Price Target to $23 From $21, Keeps Equalweight Rating MT
UBS Cuts Owens & Minor Price Target to $26 From $28, Maintains Buy Rating MT
UBS Adjusts Owens & Minor Price Target to $28 From $22, Maintains Buy Rating MT
JPMorgan Adjusts Owens & Minor's Price Target to $19 From $21, Maintains Underweight Rating MT
Baird Adjusts Owens & Minor's Price Target to $18 From $21, Maintains Neutral Rating MT
Credit Suisse Adjusts Owens & Minor's Price Target to $19 From $18, Keeps Neutral Rating MT
Citigroup Adjusts Owens & Minor's Price Target to $23 From $17, Keeps Neutral Rating MT
UBS Adjusts Owens & Minor Price Target to $24 From $22, Maintains Buy Rating MT
Credit Suisse Lifts Owens & Minor's Price Target to $18 From $17 After Above-Consensus Q1 Earnings, Keeps Neutral Rating MT
Baird Adjusts Owens & Minor Price Target to $21 From $18, Maintains Neutral Rating MT
UBS Lowers Owens & Minor's Price Target to $22 From $25, Maintains Buy Rating MT
Citigroup Adjusts Price Target on Owens & Minor to $17 From $20, Maintains Neutral Rating MT
Credit Suisse Lowers Owens & Minor's Price Target to $17 From $20 After Below-Consensus Q4 Earnings, 2023 Guidance; Keeps Neutral Rating MT
UBS Adjusts Owens & Minor's Price Target to $25 From $23, Maintains Buy Rating MT
Fitch Affirms Medline's Rating at 'B+'; Outlook Remains Negative AQ
Citigroup Adjusts Price Target on Owens & Minor to $20 From $18, Maintains Neutral Rating MT
UBS Lowers Owens & Minor's PT to $23 From $35, Keeps Buy Rating; Says Channel Checks Suggest H2 Products Segment Hit to Linger MT
Credit Suisse Lowers Owens & Minor's PT to $20 from $37, Reducing Estimates on Disappointing Q3 Earnings Preview; Keeps Neutral Rating MT
Citigroup Downgrades Owens & Minor to Neutral From Buy, Adjusts Price Target to $18 From $52 MT
ANALYST RECOMMENDATIONS : Biogen, Colgate, Comcast, Glencore, Sage... Our Logo
BofA Securities Downgrades Owens & Minor to Underperform From Buy, Adjusts Price Target to $17 From $43 MT
Baird Downgrades Owens & Minor to Neutral From Outperform, Adjusts Price Target to $22 From $62 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
27.95 USD
Average target price
23.29 USD
Spread / Average Target
-16.69%
High Price Target
27 USD
Spread / Highest target
-3.40%
Low Price Target
19 USD
Spread / Lowest Target
-32.02%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Owens & Minor, Inc.

Barclays
UBS
Citigroup
JPMorgan Chase
Baird
Credit Suisse
Cowen
BofA Securities
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
  1. Stock
  2. Equities
  3. Stock Owens & Minor, Inc. - Nyse
  4. Consensus Owens & Minor, Inc.